{"id":"https://openalex.org/A5117090455","orcid":"https://orcid.org/0000-0003-3791-0801","observed_orcids":["https://orcid.org/0000-0003-3791-0801"],"display_name":"Carina Jungha Dumo","raw_author_names":["Carina Dumo","Carina J. Dumo","Carina Jungha Dumo"],"full_name":"Carina Jungha Dumo","works_count":6,"cited_by_count":8,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":1,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5117090455","orcid":"https://orcid.org/0000-0003-3791-0801","observed_orcids":["https://orcid.org/0000-0003-3791-0801"]},"affiliations":[{"institution":{"id":"https://openalex.org/I154130895","ror":"https://ror.org/03b94tp07","display_name":"University of Auckland","country_code":"NZ","type":"education","lineage":["https://openalex.org/I154130895"]},"years":[2026,2025]}],"last_known_institutions":[{"id":"https://openalex.org/I154130895","ror":"https://ror.org/03b94tp07","display_name":"University of Auckland","country_code":"NZ","type":"education","lineage":["https://openalex.org/I154130895"]}],"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","count":6,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","count":2,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","count":2,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","count":1,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","count":1,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","value":1.72e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","value":1.68e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","value":1.64e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","value":8e-06,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","value":7.7e-06,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.734499990940094},{"id":"502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","score":0.6449999809265137},{"id":"81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","score":0.6144999861717224},{"id":"2776194525","wikidata":"https://www.wikidata.org/wiki/Q282142","display_name":"Glioblastoma","score":0.588310182094574},{"id":"1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","score":0.37299999594688416}],"counts_by_year":[{"year":2025,"works_count":2,"oa_works_count":1,"cited_by_count":0},{"year":2026,"works_count":4,"oa_works_count":3,"cited_by_count":8}],"display_name_alternatives":["Carina Dumo","Carina J. Dumo","Carina Jungha Dumo"],"block_key":"c dumo","works_api_url":"https://api.openalex.org/works?filter=author.id:A5117090455","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5117090455","updated_date":"2026-11-17T13:41:00","created_date":"2025-04-10T00:00:00"}
